Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
| (1) | Registration Statements (Form S-3 Nos. 333-265277, 333-275261 and 333-276488) of BioXcel Therapeutics, Inc., and |
| (2) | Registration Statements (Form S-8 Nos. 333-235282, 333-238580, 333-266922 and 333-270652) pertaining to the 2017 Equity Incentive Plan and the 2020 Incentive Award Plan and 2020 Employee Stock Purchase Plan of BioXcel Therapeutics, Inc. |
of our report dated March 22, 2024, with respect to the consolidated financial statements of BioXcel Therapeutics, Inc. included in this Annual Report (Form 10-K) of BioXcel Therapeutics, Inc. for the year ended December 31, 2023.
/s/ Ernst & Young, LLP
Stamford, Connecticut
March 22, 2024